TrialMolecular and cellular biochemistry2018

Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy.

Nataliya Babyshkina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.